| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A ABCA1 ABCA3 IPO8 TMC7 TRPC3 TRPC6 ABCC11 SLC10A3 TMC4 KCNK7 SLC7A11 SLC18B1 ABCA7 RYR1 CALHM2 SLCO1B7 SLC38A1 SLC7A2 ZACN SLC10A1 SLC30A5 ATP8A1 CLCA2 SLC18A2 SLC22A3 SLC22A5 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 SLC38A6 MFSD10 | 4.32e-12 | 1180 | 147 | 34 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SCN11A ABCA1 ABCA3 IPO8 TMC7 CETP TRPC3 TRPC6 ABCC11 SLC10A3 TMC4 KCNK7 SLC7A11 SLC18B1 ABCA7 RYR1 CALHM2 SLCO1B7 SLC38A1 SLC7A2 ZACN SLC10A1 SLC30A5 ATP8A1 CLCA2 SLC18A2 SLC22A3 SLC22A5 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 SLC38A6 MFSD10 | 1.04e-11 | 1289 | 147 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 ABCA3 IPO8 ABCC11 SLC10A3 SLC7A11 SLC18B1 ABCA7 SLCO1B7 SLC38A1 SLC10A1 SLC30A5 ATP8A1 SLC18A2 SLC22A3 SLC22A5 SLC38A7 CTNS SLC41A1 SLC4A5 | 3.54e-10 | 477 | 147 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A TMC7 TRPC3 TRPC6 SLC10A3 TMC4 KCNK7 SLC18B1 RYR1 CALHM2 SLC38A1 ZACN SLC10A1 SLC30A5 ATP8A1 CLCA2 SLC18A2 SLC22A3 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 | 1.83e-08 | 793 | 147 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC10A3 SLC7A11 SLC18B1 SLCO1B7 SLC38A1 SLC10A1 SLC30A5 SLC18A2 SLC22A3 SLC22A5 SLC38A7 CTNS SLC41A1 SLC4A5 | 4.15e-08 | 296 | 147 | 14 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ABCA1 OR4N5 DDR2 OR10Q1 OR2W5P ADGRV1 GABBR2 PTGDR LGR5 ABCA7 S1PR1 CRHR1 OR8G1 ZACN LMBR1L TAS2R33 CD300LB SCN7A MRGPRX2 C3AR1 OR52W1 GPR171 ADGRF3 TAS2R45 NCR2 OR56A1 TAS2R19 TAS2R30 TAS2R46 ADGRF1 | 4.44e-08 | 1353 | 147 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A TRPC3 TRPC6 SLC10A3 KCNK7 SLC18B1 RYR1 CALHM2 SLC38A1 ZACN SLC10A1 SLC30A5 ATP8A1 SLC18A2 SLC22A3 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 | 9.31e-08 | 664 | 147 | 20 | GO:0008324 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC11 SLC10A3 SLC7A11 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC22A3 SLC38A7 CTNS SLC4A5 SLC38A6 MFSD10 | 2.70e-07 | 293 | 147 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR4N5 OR10Q1 OR2W5P ADGRV1 GABBR2 PTGDR LGR5 S1PR1 CRHR1 OR8G1 TAS2R33 MRGPRX2 C3AR1 OR52W1 GPR171 ADGRF3 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 ADGRF1 | 5.40e-07 | 884 | 147 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC10A3 SLC38A1 SLC10A1 SLC18A2 SLC22A3 SCN7A SLC38A7 SLC41A1 SLC4A5 | 5.64e-07 | 171 | 147 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 8.26e-07 | 70 | 147 | 7 | GO:1901618 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.43e-06 | 27 | 147 | 5 | GO:0033038 | |
| GeneOntologyMolecularFunction | symporter activity | SLC10A3 SLC38A1 SLC10A1 SLC18A2 SLC22A3 SLC22A5 SLC38A7 CTNS SLC4A5 | 1.71e-06 | 150 | 147 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A TRPC3 TRPC6 SLC10A3 KCNK7 RYR1 SLC38A1 SLC10A1 SLC30A5 SLC18A2 SLC22A3 SCN7A SLC38A7 SLC41A1 SLC4A5 | 1.82e-06 | 465 | 147 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.24e-06 | 81 | 147 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC10A3 SLC18B1 SLC38A1 SLC10A1 SLC30A5 ATP8A1 SLC18A2 SLC22A3 SLC38A7 CTNS SLC41A1 SLC4A5 | 2.42e-06 | 301 | 147 | 12 | GO:0022853 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.81e-06 | 119 | 147 | 8 | GO:0015294 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN11A TRPC3 TRPC6 ABCC11 SLC10A3 KCNK7 SLC18B1 RYR1 SLC38A1 SLC10A1 SLC30A5 CLCA2 SLC18A2 SLC22A3 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 | 3.12e-06 | 758 | 147 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCC11 SLC10A3 SLC7A11 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC38A7 CTNS SLC38A6 | 3.19e-06 | 207 | 147 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCC11 SLC10A3 SLC7A11 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC38A7 CTNS SLC38A6 | 3.33e-06 | 208 | 147 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN11A TRPC3 TRPC6 SLC10A3 KCNK7 SLC18B1 RYR1 SLC38A1 SLC10A1 SLC30A5 SLC18A2 SLC22A3 SCN7A SLC38A7 CTNS SLC41A1 SLC4A5 | 3.83e-06 | 627 | 147 | 17 | GO:0022890 |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 3.87e-06 | 5 | 147 | 3 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 3.87e-06 | 5 | 147 | 3 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 3.87e-06 | 5 | 147 | 3 | GO:0008823 | |
| GeneOntologyMolecularFunction | taste receptor activity | 4.06e-06 | 33 | 147 | 5 | GO:0008527 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 1.34e-05 | 7 | 147 | 3 | GO:0016723 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.39e-05 | 71 | 147 | 6 | GO:0015179 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCA1 ABCA3 CETP ABCC11 SLC10A3 ABCA7 SLCO1B7 SLC10A1 ATP8A1 | 1.51e-05 | 196 | 147 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | endopeptidase activity | CAPN14 ZMPSTE24 ADAM9 TMPRSS4 ERVK-9 SPPL2B CLCA2 LPA TMPRSS3 ADAMTS20 ERVK-19 TPSG1 MMP16 | 1.82e-05 | 430 | 147 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 3.18e-05 | 9 | 147 | 3 | GO:0015186 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 3.18e-05 | 9 | 147 | 3 | GO:0090556 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.40e-05 | 83 | 147 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.03e-05 | 28 | 147 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor activity | 5.38e-05 | 2 | 147 | 2 | GO:0034188 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity | 5.38e-05 | 2 | 147 | 2 | GO:0004583 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 8.19e-05 | 12 | 147 | 3 | GO:0008504 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.10e-04 | 34 | 147 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.10e-04 | 34 | 147 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.24e-04 | 35 | 147 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.27e-04 | 105 | 147 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.56e-04 | 109 | 147 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 1.61e-04 | 3 | 147 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | floppase activity | 2.04e-04 | 16 | 147 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.16e-04 | 74 | 147 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 2.94e-04 | 18 | 147 | 3 | GO:0016722 | |
| GeneOntologyMolecularFunction | monoamine:proton antiporter activity | 3.20e-04 | 4 | 147 | 2 | GO:0015311 | |
| GeneOntologyMolecularFunction | alanine:sodium symporter activity | 3.20e-04 | 4 | 147 | 2 | GO:0015655 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 4.07e-04 | 20 | 147 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.13e-04 | 85 | 147 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.62e-04 | 49 | 147 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 5.39e-04 | 51 | 147 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 5.43e-04 | 22 | 147 | 3 | GO:0046527 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.56e-04 | 138 | 147 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN11A TMC7 TRPC3 TRPC6 TMC4 KCNK7 RYR1 CALHM2 ZACN CLCA2 SCN7A | 6.03e-04 | 459 | 147 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | bile acid:sodium symporter activity | 7.92e-04 | 6 | 147 | 2 | GO:0008508 | |
| GeneOntologyMolecularFunction | alcohol binding | 9.49e-04 | 102 | 147 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | peptidase activity | CAPN14 ZMPSTE24 ADAM9 TMPRSS4 ERVK-9 SPPL2B CLCA2 LPA TMPRSS3 ADAMTS20 ERVK-19 TPSG1 MMP16 | 1.11e-03 | 654 | 147 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.46e-03 | 8 | 147 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.46e-03 | 8 | 147 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | channel activity | SCN11A TMC7 TRPC3 TRPC6 TMC4 KCNK7 RYR1 CALHM2 ZACN CLCA2 SCN7A | 1.78e-03 | 525 | 147 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN11A TMC7 TRPC3 TRPC6 TMC4 KCNK7 RYR1 CALHM2 ZACN CLCA2 SCN7A | 1.80e-03 | 526 | 147 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.81e-03 | 33 | 147 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.87e-03 | 9 | 147 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.95e-03 | 120 | 147 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.07e-03 | 178 | 147 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.07e-03 | 73 | 147 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.53e-03 | 37 | 147 | 3 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.73e-03 | 38 | 147 | 3 | GO:0070001 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 2.83e-03 | 11 | 147 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 2.83e-03 | 11 | 147 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 3.02e-03 | 81 | 147 | 4 | GO:0042379 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.37e-03 | 334 | 147 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 3.38e-03 | 12 | 147 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 3.40e-03 | 41 | 147 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.95e-03 | 343 | 147 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | CCR6 chemokine receptor binding | 3.98e-03 | 13 | 147 | 2 | GO:0031731 | |
| GeneOntologyMolecularFunction | FAD binding | 4.15e-03 | 44 | 147 | 3 | GO:0071949 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.41e-03 | 90 | 147 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.62e-03 | 14 | 147 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.62e-03 | 14 | 147 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 5.15e-03 | 94 | 147 | 4 | GO:0050660 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 5.31e-03 | 15 | 147 | 2 | GO:0015651 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 5.31e-03 | 15 | 147 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 5.31e-03 | 15 | 147 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 5.31e-03 | 15 | 147 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | protein antigen binding | 6.04e-03 | 16 | 147 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 6.04e-03 | 16 | 147 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 6.81e-03 | 17 | 147 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | flippase activity | 6.81e-03 | 17 | 147 | 2 | GO:0140327 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A ZMPSTE24 TMC7 TRPC3 TRPC6 STEAP4 ABCC11 TMC4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B CALHM2 SLCO1B7 SLC38A1 ZACN SLC10A1 SLC30A5 ATP8A1 CLCA2 SLC18A2 SLC22A3 SLC22A5 SCN7A SLC38A7 STEAP3 CTNS SLC41A1 SLC4A5 CREB3 | 1.68e-09 | 1374 | 146 | 32 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A ZMPSTE24 TRPC3 TRPC6 STEAP4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B CALHM2 SLC38A1 ZACN SLC10A1 SLC30A5 ATP8A1 SLC18A2 SLC22A5 SCN7A SLC38A7 STEAP3 CTNS SLC41A1 SLC4A5 CREB3 | 1.48e-07 | 1157 | 146 | 26 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A TMC7 TRPC3 TRPC6 STEAP4 ABCC11 TMC4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B CALHM2 SLC38A1 ZACN SLC30A5 ATP8A1 CLCA2 SLC18A2 SCN7A STEAP3 CTNS SLC41A1 SLC4A5 | 2.79e-07 | 1115 | 146 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | ABCA1 ABCA3 CETP ABCC11 SLC10A3 SLC18B1 ABCA7 CRHR1 SLCO1B7 SLC10A1 SLC18A2 SLC22A3 MFSD10 | 1.66e-06 | 358 | 146 | 13 | GO:0015850 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN11A TRPC3 TRPC6 STEAP4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B CALHM2 SLC38A1 ZACN SLC30A5 ATP8A1 SLC18A2 SCN7A STEAP3 CTNS SLC41A1 SLC4A5 | 3.08e-06 | 942 | 146 | 21 | GO:0098655 |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid transport | 3.09e-06 | 15 | 146 | 4 | GO:2001140 | |
| GeneOntologyBiologicalProcess | iron ion import across cell outer membrane | 3.44e-06 | 5 | 146 | 3 | GO:0098706 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid transport | 4.10e-06 | 16 | 146 | 4 | GO:2001138 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | SCN11A ABCA1 OR4N5 OR10Q1 OR2W5P ADGRV1 GABBR2 PTGDR LGR5 ZDHHC3 S1PR1 CRHR1 OR8G1 PLPPR4 TAS2R33 MRGPRX2 C3AR1 OR52W1 GPR171 ADGRF3 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 ADGRF1 | 4.97e-06 | 1395 | 146 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A ZMPSTE24 TRPC3 TRPC6 STEAP4 STEAP2 KCNK7 CRHR1 RYR1 ALG10B CALHM2 SLC38A1 SLC10A1 SLC30A5 SLC22A5 SCN7A SLC38A7 STEAP3 SLC41A1 SLC4A5 CREB3 | 7.74e-06 | 1000 | 146 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 1.44e-05 | 44 | 146 | 5 | GO:0001580 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | SCN11A PILRB ADAM9 PTGDR CRHR1 CALHM2 SLC7A2 SLC18A2 CD300LB MRGPRX2 ATM | 1.80e-05 | 320 | 146 | 11 | GO:0002274 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC11 SLC10A3 SLC7A11 CALHM2 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC22A3 SLC38A7 CTNS SLC4A5 SLC38A6 MFSD10 | 1.82e-05 | 515 | 146 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 2.22e-05 | 48 | 146 | 5 | GO:0050913 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 2.72e-05 | 50 | 146 | 5 | GO:0050912 | |
| GeneOntologyBiologicalProcess | copper ion import | 2.83e-05 | 9 | 146 | 3 | GO:0015677 | |
| GeneOntologyBiologicalProcess | glutamine transport | 4.02e-05 | 10 | 146 | 3 | GO:0006868 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 6.62e-05 | 60 | 146 | 5 | GO:0015804 | |
| GeneOntologyBiologicalProcess | iron import into cell | 7.29e-05 | 12 | 146 | 3 | GO:0033212 | |
| GeneOntologyBiologicalProcess | mast cell activation | 8.28e-05 | 101 | 146 | 6 | GO:0045576 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 9.04e-05 | 64 | 146 | 5 | GO:0042908 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A TRPC3 TRPC6 STEAP4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B SLC38A1 SLC30A5 SLC18A2 SCN7A STEAP3 CTNS SLC41A1 SLC4A5 | 9.32e-05 | 922 | 146 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN11A TRPC3 TRPC6 STEAP4 STEAP2 KCNK7 SLC18B1 CRHR1 RYR1 ALG10B SLC38A1 SLC30A5 CLCA2 SLC18A2 SCN7A STEAP3 CTNS SLC41A1 SLC4A5 | 1.05e-04 | 1017 | 146 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | serotonin uptake | 1.19e-04 | 14 | 146 | 3 | GO:0051610 | |
| GeneOntologyBiologicalProcess | sensory perception of taste | 1.39e-04 | 70 | 146 | 5 | GO:0050909 | |
| GeneOntologyBiologicalProcess | phospholipid efflux | 1.49e-04 | 15 | 146 | 3 | GO:0033700 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.57e-04 | 162 | 146 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC11 SLC10A3 SLC7A11 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC22A3 SLC38A7 CTNS SLC38A6 | 1.66e-04 | 410 | 146 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | ABCC11 SLC10A3 SLC7A11 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC22A3 SLC38A7 CTNS SLC38A6 | 1.73e-04 | 412 | 146 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | mast cell degranulation | 1.80e-04 | 74 | 146 | 5 | GO:0043303 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 1.81e-04 | 40 | 146 | 4 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 1.81e-04 | 40 | 146 | 4 | GO:0032376 | |
| GeneOntologyBiologicalProcess | mast cell mediated immunity | 2.05e-04 | 76 | 146 | 5 | GO:0002448 | |
| GeneOntologyBiologicalProcess | mast cell activation involved in immune response | 2.31e-04 | 78 | 146 | 5 | GO:0002279 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | SCN11A OR4N5 OR10Q1 OR2W5P ADGRV1 OR8G1 TAS2R33 OR52W1 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 | 2.60e-04 | 582 | 146 | 13 | GO:0050906 |
| GeneOntologyBiologicalProcess | phospholipid homeostasis | 2.62e-04 | 18 | 146 | 3 | GO:0055091 | |
| GeneOntologyBiologicalProcess | lipid transport | ABCA1 ABCA3 CETP ABCC11 SLC10A3 ABCA7 CRHR1 SLCO1B7 SLC10A1 ATP8A1 PLPPR4 LPA | 2.63e-04 | 506 | 146 | 12 | GO:0006869 |
| GeneOntologyBiologicalProcess | histamine uptake | 2.96e-04 | 4 | 146 | 2 | GO:0051615 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid efflux | 2.96e-04 | 4 | 146 | 2 | GO:1902994 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid efflux | 2.96e-04 | 4 | 146 | 2 | GO:1902995 | |
| GeneOntologyBiologicalProcess | positive regulation of hepatic stellate cell proliferation | 2.96e-04 | 4 | 146 | 2 | GO:1904899 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.39e-04 | 47 | 146 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | copper ion transport | 3.63e-04 | 20 | 146 | 3 | GO:0006825 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 3.85e-04 | 87 | 146 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 4.05e-04 | 88 | 146 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | dolichol-linked oligosaccharide biosynthetic process | 4.85e-04 | 22 | 146 | 3 | GO:0006488 | |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 5.01e-04 | 52 | 146 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | sensory perception | SCN11A OR4N5 OR10Q1 OR2W5P ADGRV1 ALG10B OR8G1 TAS2R33 TMPRSS3 MRGPRX2 OR52W1 GPR171 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 IMPG2 | 5.82e-04 | 1072 | 146 | 18 | GO:0007600 |
| GeneOntologyBiologicalProcess | organic cation transport | 5.89e-04 | 145 | 146 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | import into cell | ABCA1 AMN CXCL16 TSC2 HEATR5A SIRPB2 SIRPB1 STEAP2 SLC7A11 SLC18B1 ABCA7 SLC38A1 SLC7A2 SLC30A5 ATP8A1 LMBR1L SLC18A2 SLC22A3 | 5.95e-04 | 1074 | 146 | 18 | GO:0098657 |
| GeneOntologyBiologicalProcess | detection of stimulus | SCN11A OR4N5 TRPC3 OR10Q1 OR2W5P ADGRV1 OR8G1 TAS2R33 OR52W1 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 | 6.22e-04 | 722 | 146 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | dolichol metabolic process | 6.31e-04 | 24 | 146 | 3 | GO:0019348 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 6.56e-04 | 148 | 146 | 6 | GO:0002444 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol efflux | 6.65e-04 | 56 | 146 | 4 | GO:0010874 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4N5 OR10Q1 OR2W5P OR8G1 TAS2R33 OR52W1 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 | 6.87e-04 | 485 | 146 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | lipid localization | ABCA1 ABCA3 CETP ABCC11 SLC10A3 ABCA7 CRHR1 SLCO1B7 SLC10A1 ATP8A1 PLPPR4 LPA | 7.01e-04 | 565 | 146 | 12 | GO:0010876 |
| GeneOntologyBiologicalProcess | hepatic stellate cell proliferation | 7.33e-04 | 6 | 146 | 2 | GO:1990922 | |
| GeneOntologyBiologicalProcess | regulation of hepatic stellate cell proliferation | 7.33e-04 | 6 | 146 | 2 | GO:1904897 | |
| GeneOntologyBiologicalProcess | L-cystine transport | 7.33e-04 | 6 | 146 | 2 | GO:0015811 | |
| GeneOntologyBiologicalProcess | spermidine transport | 7.33e-04 | 6 | 146 | 2 | GO:0015848 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 7.79e-04 | 275 | 146 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 7.97e-04 | 102 | 146 | 5 | GO:0032370 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 8.11e-04 | 59 | 146 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | lipid translocation | 8.64e-04 | 60 | 146 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 8.97e-04 | 27 | 146 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 9.48e-04 | 106 | 146 | 5 | GO:0015914 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 9.85e-04 | 160 | 146 | 6 | GO:0048144 | |
| GeneOntologyBiologicalProcess | lysosome localization | 9.88e-04 | 107 | 146 | 5 | GO:0032418 | |
| GeneOntologyBiologicalProcess | vacuolar localization | 9.88e-04 | 107 | 146 | 5 | GO:1990849 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.00e-03 | 286 | 146 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone generation | 1.02e-03 | 7 | 146 | 2 | GO:2000609 | |
| GeneOntologyBiologicalProcess | apolipoprotein A-I-mediated signaling pathway | 1.02e-03 | 7 | 146 | 2 | GO:0038027 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 1.03e-03 | 108 | 146 | 5 | GO:0043299 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.03e-03 | 108 | 146 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.11e-03 | 29 | 146 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.17e-03 | 65 | 146 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | iron ion transmembrane transport | 1.23e-03 | 30 | 146 | 3 | GO:0034755 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4N5 OR10Q1 OR2W5P OR8G1 TAS2R33 OR52W1 TAS2R45 OR56A1 TAS2R19 TAS2R30 TAS2R46 | 1.28e-03 | 524 | 146 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 1.31e-03 | 114 | 146 | 5 | GO:0070167 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | TRPC3 TRPC6 STEAP4 STEAP2 RYR1 BCAP31 SLC30A5 TMPRSS3 SCN7A STEAP3 SLC41A1 SLC4A5 | 1.37e-03 | 611 | 146 | 12 | GO:0030003 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 4.25e-06 | 35 | 146 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.09e-05 | 48 | 146 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | basal plasma membrane | ABCA1 ADAM9 SLCO1B7 SLC38A1 SLC10A1 CLCA2 SLC22A3 SLC22A5 SLC41A1 SLC4A5 | 1.97e-04 | 354 | 146 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | apical part of cell | AMN DDR2 ABCC11 SLC7A11 ABCA7 CRHR1 SLC38A1 PROM1 SLC30A5 SLC22A3 SLC22A5 SLC4A5 DUOXA2 | 2.69e-04 | 592 | 146 | 13 | GO:0045177 |
| GeneOntologyCellularComponent | basal part of cell | ABCA1 ADAM9 SLCO1B7 SLC38A1 SLC10A1 CLCA2 SLC22A3 SLC22A5 SLC41A1 SLC4A5 | 3.33e-04 | 378 | 146 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | side of membrane | ABCA1 CD248 ADAM9 SPPL2B ITGAE S1PR1 RYR1 ALG10B SLC38A1 BTN2A2 BCAP31 PLPPR4 LPA ALG8 ALG6 BTNL9 | 4.16e-04 | 875 | 146 | 16 | GO:0098552 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCA1 ADAM9 SLCO1B7 SLC38A1 SLC10A1 SLC22A3 SLC22A5 SLC41A1 SLC4A5 | 4.26e-04 | 320 | 146 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | periciliary membrane compartment | 7.13e-04 | 6 | 146 | 2 | GO:1990075 | |
| Domain | ProC_N | 1.41e-05 | 7 | 140 | 3 | IPR028939 | |
| Domain | F420_oxidored | 1.41e-05 | 7 | 140 | 3 | PF03807 | |
| Domain | TAS2R | 3.98e-05 | 26 | 140 | 4 | PF05296 | |
| Domain | T2R | 3.98e-05 | 26 | 140 | 4 | IPR007960 | |
| Domain | Glyco_trans_ALG6/ALG8 | 5.58e-05 | 2 | 140 | 2 | IPR004856 | |
| Domain | Alg6_Alg8 | 5.58e-05 | 2 | 140 | 2 | PF03155 | |
| Domain | Ferric_reduct | 8.63e-05 | 12 | 140 | 3 | PF01794 | |
| Domain | ABC_A | 8.63e-05 | 12 | 140 | 3 | IPR026082 | |
| Domain | Fe3_Rdtase_TM_dom | 8.63e-05 | 12 | 140 | 3 | IPR013130 | |
| Domain | MFS | 1.63e-04 | 108 | 140 | 6 | PS50850 | |
| Domain | GPCR_2_extracellular_dom | 2.24e-04 | 40 | 140 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.24e-04 | 40 | 140 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.24e-04 | 40 | 140 | 4 | PS50227 | |
| Domain | Aa_trans | 2.60e-04 | 17 | 140 | 3 | PF01490 | |
| Domain | AA_transpt_TM | 2.60e-04 | 17 | 140 | 3 | IPR013057 | |
| Domain | ABC_transporter_CS | 2.71e-04 | 42 | 140 | 4 | IPR017871 | |
| Domain | Bilac:Na_transpt | 3.31e-04 | 4 | 140 | 2 | IPR004710 | |
| Domain | ABC_tran | 4.56e-04 | 48 | 140 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.56e-04 | 48 | 140 | 4 | PS50893 | |
| Domain | V-set | 4.80e-04 | 184 | 140 | 7 | PF07686 | |
| Domain | ABC_TRANSPORTER_1 | 4.93e-04 | 49 | 140 | 4 | PS00211 | |
| Domain | MFS_dom | 5.21e-04 | 134 | 140 | 6 | IPR020846 | |
| Domain | 7tm_2 | 5.33e-04 | 50 | 140 | 4 | PF00002 | |
| Domain | ABC_transporter-like | 5.33e-04 | 50 | 140 | 4 | IPR003439 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.33e-04 | 50 | 140 | 4 | PS00650 | |
| Domain | Ig_V-set | 7.64e-04 | 199 | 140 | 7 | IPR013106 | |
| Domain | TRP_2 | 8.20e-04 | 6 | 140 | 2 | PF08344 | |
| Domain | TRP_dom | 8.20e-04 | 6 | 140 | 2 | IPR013555 | |
| Domain | GPCR_2_secretin-like | 1.07e-03 | 60 | 140 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.07e-03 | 60 | 140 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.13e-03 | 61 | 140 | 4 | PS50261 | |
| Domain | SBF | 1.14e-03 | 7 | 140 | 2 | PF01758 | |
| Domain | TRPC_channel | 1.14e-03 | 7 | 140 | 2 | IPR002153 | |
| Domain | SRCR_2 | 1.14e-03 | 7 | 140 | 2 | PF15494 | |
| Domain | BilAc:Na_symport/Acr3 | 1.14e-03 | 7 | 140 | 2 | IPR002657 | |
| Domain | TMC | 1.52e-03 | 8 | 140 | 2 | PF07810 | |
| Domain | TMC | 1.52e-03 | 8 | 140 | 2 | IPR012496 | |
| Domain | Ion_trans_dom | 1.68e-03 | 114 | 140 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.68e-03 | 114 | 140 | 5 | PF00520 | |
| Domain | Orgcat_transp/SVOP | 1.94e-03 | 9 | 140 | 2 | IPR004749 | |
| Domain | GPS | 2.08e-03 | 34 | 140 | 3 | SM00303 | |
| Domain | GPS | 2.26e-03 | 35 | 140 | 3 | PF01825 | |
| Domain | Na_channel_asu | 2.41e-03 | 10 | 140 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.41e-03 | 10 | 140 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.41e-03 | 10 | 140 | 2 | PF06512 | |
| Domain | GPS | 2.46e-03 | 36 | 140 | 3 | PS50221 | |
| Domain | GPS | 2.66e-03 | 37 | 140 | 3 | IPR000203 | |
| Domain | MFS_1 | 2.68e-03 | 77 | 140 | 4 | PF07690 | |
| Domain | MFS | 2.68e-03 | 77 | 140 | 4 | IPR011701 | |
| Domain | TRP_channel | 2.94e-03 | 11 | 140 | 2 | IPR004729 | |
| Domain | Defensin_beta-typ | 3.51e-03 | 12 | 140 | 2 | IPR001855 | |
| Domain | Defensin_beta | 3.51e-03 | 12 | 140 | 2 | PF00711 | |
| Domain | AA_permease_2 | 4.12e-03 | 13 | 140 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 4.12e-03 | 13 | 140 | 2 | IPR002293 | |
| Domain | GPCR_Rhodpsn_7TM | OR4N5 OR10Q1 OR2W5P PTGDR LGR5 S1PR1 OR8G1 MRGPRX2 C3AR1 OR52W1 GPR171 OR56A1 | 4.60e-03 | 670 | 140 | 12 | IPR017452 |
| Domain | 7tm_1 | OR4N5 OR10Q1 OR2W5P PTGDR LGR5 S1PR1 OR8G1 MRGPRX2 C3AR1 OR52W1 GPR171 OR56A1 | 4.99e-03 | 677 | 140 | 12 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR4N5 OR10Q1 OR2W5P PTGDR LGR5 S1PR1 OR8G1 MRGPRX2 C3AR1 OR52W1 GPR171 OR56A1 | 5.46e-03 | 685 | 140 | 12 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR4N5 OR10Q1 OR2W5P PTGDR LGR5 S1PR1 OR8G1 MRGPRX2 C3AR1 OR52W1 GPR171 OR56A1 | 5.84e-03 | 691 | 140 | 12 | PS50262 |
| Domain | GPCR_Rhodpsn | OR4N5 OR10Q1 OR2W5P PTGDR LGR5 S1PR1 OR8G1 MRGPRX2 C3AR1 OR52W1 GPR171 OR56A1 | 5.91e-03 | 692 | 140 | 12 | IPR000276 |
| Domain | ZINC_PROTEASE | 6.34e-03 | 98 | 140 | 4 | PS00142 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 ABCA3 AMN CETP TRPC3 TRPC6 STEAP4 ABCC11 SLC7A11 ABCA7 RYR1 SLC38A1 SLC7A2 SLC30A5 ATP8A1 CLCA2 SLC18A2 LPA SLC22A3 SLC22A5 STEAP3 CTNS SLC41A1 SLC4A5 | 2.53e-09 | 736 | 112 | 24 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCA1 ABCA3 TRPC3 TRPC6 STEAP4 SLC7A11 ABCA7 RYR1 SLCO1B7 SLC38A1 SLC30A5 ATP8A1 CLCA2 SLC18A2 SLC22A3 SLC22A5 STEAP3 CTNS SLC41A1 SLC4A5 | 3.59e-07 | 681 | 112 | 20 | MM14985 |
| Pathway | WP_GPCRS_ODORANT | LGR5 MRGPRX2 GPR171 ADGRF3 TAS2R45 TAS2R19 TAS2R30 TAS2R46 ADGRF1 | 4.33e-06 | 157 | 112 | 9 | MM15872 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.03e-05 | 37 | 112 | 5 | MM15067 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A11 SLCO1B7 SLC38A1 SLC30A5 SLC18A2 SLC22A3 SLC22A5 CTNS SLC41A1 SLC4A5 | 1.95e-05 | 238 | 112 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A11 SLC38A1 SLC7A2 SLC30A5 SLC18A2 SLC22A3 SLC22A5 CTNS SLC41A1 SLC4A5 | 2.88e-05 | 249 | 112 | 10 | M5988 |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST | 7.69e-05 | 11 | 112 | 3 | M47614 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.01e-04 | 31 | 112 | 4 | MM15691 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | TEX261 ABCA1 CETP TMPRSS4 TSC2 HEATR5A STEAP2 ACOX2 LMBR1L LPA TMPRSS3 | 2.22e-04 | 381 | 112 | 11 | M48063 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 2.51e-04 | 39 | 112 | 4 | M793 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.41e-04 | 76 | 112 | 5 | MM15072 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.01e-04 | 44 | 112 | 4 | M11911 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.42e-04 | 84 | 112 | 5 | M27334 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CXCL16 GABBR2 PTGDR S1PR1 CRHR1 PLPPR4 C3AR1 TAS2R45 TAS2R19 TAS2R30 TAS2R46 | 6.17e-04 | 430 | 112 | 11 | MM15160 |
| Pathway | WP_COPPER_HOMEOSTASIS | 8.19e-04 | 53 | 112 | 4 | M39349 | |
| Pathway | REACTOME_LDL_REMODELING | 9.19e-04 | 6 | 112 | 2 | M42520 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 19198611 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 23036009 | ||
| Pubmed | STAMPing at the crossroads of normal physiology and disease states. | 7.40e-08 | 3 | 147 | 3 | 26911931 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 27417586 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 1.48e-07 | 12 | 147 | 4 | 12379855 | |
| Pubmed | 2.13e-07 | 13 | 147 | 4 | 15938754 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 21900290 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 34649092 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 16609065 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 17142808 | ||
| Pubmed | Genetic and clinical correlates of early-outgrowth colony-forming units. | 7.35e-07 | 5 | 147 | 3 | 21493818 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 12429817 | ||
| Pubmed | 1.73e-06 | 21 | 147 | 4 | 10761934 | ||
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 2.11e-06 | 22 | 147 | 4 | 12734386 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 2.55e-06 | 23 | 147 | 4 | 20022913 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ZMPSTE24 ADAM9 HUWE1 STEAP2 ZDHHC3 INTS8 SLC18B1 DICER1 BCAP31 SLC30A5 SLC22A5 STEAP3 ALG8 SGCE ATM ALG6 MFSD10 | 2.75e-06 | 1061 | 147 | 17 | 33845483 |
| Pubmed | 3.62e-06 | 25 | 147 | 4 | 12139982 | ||
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 24293640 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 4.26e-06 | 26 | 147 | 4 | 11696554 | |
| Pubmed | 4.98e-06 | 27 | 147 | 4 | 12581520 | ||
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 5.80e-06 | 28 | 147 | 4 | 15744053 | |
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 22454430 | ||
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | 7.71e-06 | 30 | 147 | 4 | 17273929 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 7.71e-06 | 30 | 147 | 4 | 12679530 | |
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 9.15e-06 | 66 | 147 | 5 | 20679960 | |
| Pubmed | 1.58e-05 | 12 | 147 | 3 | 14557543 | ||
| Pubmed | A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. | 1.77e-05 | 2 | 147 | 2 | 10825129 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22724068 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21586796 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25665932 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 1.77e-05 | 2 | 147 | 2 | 20190513 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28729361 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 38019257 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26469940 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21591583 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 33333171 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27435662 | ||
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 1.77e-05 | 2 | 147 | 2 | 12970363 | |
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 1.77e-05 | 2 | 147 | 2 | 9930701 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15897894 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26749169 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31280219 | ||
| Pubmed | Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. | 1.77e-05 | 2 | 147 | 2 | 19902402 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28373057 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24453217 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18215135 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30282721 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19131637 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29953618 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25213992 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 27861908 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 1.77e-05 | 2 | 147 | 2 | 29700422 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 14570867 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23800468 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11144347 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28105583 | ||
| Pubmed | Regulation of colonic epithelial cell homeostasis by mTORC1. | 1.77e-05 | 2 | 147 | 2 | 32796887 | |
| Pubmed | Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. | 1.77e-05 | 2 | 147 | 2 | 16484216 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 35051376 | ||
| Pubmed | Differential expression and function of stamp family proteins in adipocyte differentiation. | 1.77e-05 | 2 | 147 | 2 | 23874564 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22584245 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22306362 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19749484 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 9368034 | ||
| Pubmed | Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. | 1.77e-05 | 2 | 147 | 2 | 15930518 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28181499 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26936456 | ||
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 1.77e-05 | 2 | 147 | 2 | 35805125 | |
| Pubmed | Determination of genetic predisposition to patent ductus arteriosus in preterm infants. | 1.91e-05 | 129 | 147 | 6 | 19336370 | |
| Pubmed | TEX261 AMN C6orf89 TMPRSS4 CXCL16 STEAP2 SLC30A5 LMBR1L RNFT2 CD300LB TMPRSS3 SGCE ADGRF3 HSD17B11 BTNL9 | 1.99e-05 | 985 | 147 | 15 | 12975309 | |
| Pubmed | 3.24e-05 | 15 | 147 | 3 | 23506890 | ||
| Pubmed | 4.82e-05 | 17 | 147 | 3 | 22411552 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 24905090 | ||
| Pubmed | Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria. | 5.31e-05 | 3 | 147 | 2 | 29717979 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28790356 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15696473 | ||
| Pubmed | Selective association of TRPC channel subunits in rat brain synaptosomes. | 5.31e-05 | 3 | 147 | 2 | 12377790 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19341173 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28526717 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23938296 | ||
| Pubmed | The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer. | 5.31e-05 | 3 | 147 | 2 | 32802887 | |
| Pubmed | ATP-binding cassette transporters ABCA1, ABCA7, and ABCG1 in mouse spermatozoa. | 5.31e-05 | 3 | 147 | 2 | 18793613 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25110219 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15358862 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 21757714 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19099922 | ||
| Pubmed | Orai proteins interact with TRPC channels and confer responsiveness to store depletion. | 5.31e-05 | 3 | 147 | 2 | 17360584 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19074769 | ||
| Pubmed | 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. | 5.31e-05 | 3 | 147 | 2 | 7679504 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23181436 | ||
| Pubmed | Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. | 5.31e-05 | 3 | 147 | 2 | 19324043 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 32097940 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25852127 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12095985 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 27979597 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 36569761 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 22403608 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 10611319 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19052171 | ||
| Interaction | MBOAT7 interactions | SPPL2B BCAP31 LMBR1L SEC62 OPALIN C3AR1 SIGLECL1 HSD17B11 BTNL9 | 3.63e-06 | 182 | 134 | 9 | int:MBOAT7 |
| Interaction | CRELD1 interactions | 1.36e-05 | 163 | 134 | 8 | int:CRELD1 | |
| Interaction | CFHR5 interactions | 1.50e-05 | 23 | 134 | 4 | int:CFHR5 | |
| Interaction | DYM interactions | 1.55e-05 | 80 | 134 | 6 | int:DYM | |
| Interaction | HACD2 interactions | 1.79e-05 | 82 | 134 | 6 | int:HACD2 | |
| Interaction | BTAF1 interactions | 2.38e-05 | 128 | 134 | 7 | int:BTAF1 | |
| Interaction | ATP13A1 interactions | 2.66e-05 | 179 | 134 | 8 | int:ATP13A1 | |
| Interaction | XPO6 interactions | 2.68e-05 | 88 | 134 | 6 | int:XPO6 | |
| Interaction | TELO2 interactions | 3.35e-05 | 135 | 134 | 7 | int:TELO2 | |
| Interaction | AMIGO1 interactions | 3.89e-05 | 94 | 134 | 6 | int:AMIGO1 | |
| Interaction | CLCN7 interactions | 4.04e-05 | 139 | 134 | 7 | int:CLCN7 | |
| Interaction | CAND2 interactions | 4.13e-05 | 95 | 134 | 6 | int:CAND2 | |
| Interaction | ATP1A3 interactions | 4.16e-05 | 247 | 134 | 9 | int:ATP1A3 | |
| Interaction | PKMYT1 interactions | 4.23e-05 | 140 | 134 | 7 | int:PKMYT1 | |
| Interaction | TMCO1 interactions | 4.39e-05 | 192 | 134 | 8 | int:TMCO1 | |
| Interaction | ITPR1 interactions | 4.43e-05 | 141 | 134 | 7 | int:ITPR1 | |
| Interaction | ALG6 interactions | 5.82e-05 | 32 | 134 | 4 | int:ALG6 | |
| Interaction | TTI1 interactions | 5.83e-05 | 101 | 134 | 6 | int:TTI1 | |
| Interaction | SERINC1 interactions | 6.22e-05 | 63 | 134 | 5 | int:SERINC1 | |
| Interaction | DPEP1 interactions | 6.71e-05 | 64 | 134 | 5 | int:DPEP1 | |
| Interaction | CERS6 interactions | 6.87e-05 | 104 | 134 | 6 | int:CERS6 | |
| Interaction | SACM1L interactions | 7.13e-05 | 152 | 134 | 7 | int:SACM1L | |
| Interaction | NDC1 interactions | 7.71e-05 | 208 | 134 | 8 | int:NDC1 | |
| Interaction | CLPSL1 interactions | 7.83e-05 | 13 | 134 | 3 | int:CLPSL1 | |
| Interaction | ITPR3 interactions | 8.52e-05 | 211 | 134 | 8 | int:ITPR3 | |
| Interaction | FRMD5 interactions | 8.98e-05 | 68 | 134 | 5 | int:FRMD5 | |
| Interaction | GPX8 interactions | 8.99e-05 | 273 | 134 | 9 | int:GPX8 | |
| Interaction | CERS5 interactions | 9.33e-05 | 36 | 134 | 4 | int:CERS5 | |
| Interaction | ITM2B interactions | 1.04e-04 | 112 | 134 | 6 | int:ITM2B | |
| Interaction | AAAS interactions | 1.19e-04 | 165 | 134 | 7 | int:AAAS | |
| Interaction | VRK2 interactions | 1.21e-04 | 222 | 134 | 8 | int:VRK2 | |
| Interaction | CYB5B interactions | 1.25e-04 | 285 | 134 | 9 | int:CYB5B | |
| Interaction | HLA-A interactions | 1.38e-04 | 289 | 134 | 9 | int:HLA-A | |
| Interaction | GPR89A interactions | 1.52e-04 | 120 | 134 | 6 | int:GPR89A | |
| Interaction | TMX3 interactions | 1.59e-04 | 121 | 134 | 6 | int:TMX3 | |
| Interaction | SLC10A1 interactions | 1.59e-04 | 121 | 134 | 6 | int:SLC10A1 | |
| Interaction | BRI3BP interactions | 1.82e-04 | 124 | 134 | 6 | int:BRI3BP | |
| Interaction | PLXNB2 interactions | 1.91e-04 | 178 | 134 | 7 | int:PLXNB2 | |
| Interaction | TMX4 interactions | 1.94e-04 | 80 | 134 | 5 | int:TMX4 | |
| Interaction | UBXN8 interactions | 1.94e-04 | 80 | 134 | 5 | int:UBXN8 | |
| Interaction | PPP1R15B interactions | 2.18e-04 | 82 | 134 | 5 | int:PPP1R15B | |
| Interaction | HACD3 interactions | 2.19e-04 | 242 | 134 | 8 | int:HACD3 | |
| Interaction | GPAT4 interactions | 2.25e-04 | 129 | 134 | 6 | int:GPAT4 | |
| Interaction | SMCR8 interactions | 2.25e-04 | 129 | 134 | 6 | int:SMCR8 | |
| Interaction | CHMP7 interactions | 2.44e-04 | 84 | 134 | 5 | int:CHMP7 | |
| Interaction | CCPG1 interactions | 2.44e-04 | 84 | 134 | 5 | int:CCPG1 | |
| Interaction | YIPF3 interactions | 2.50e-04 | 186 | 134 | 7 | int:YIPF3 | |
| Interaction | SAAL1 interactions | 2.58e-04 | 187 | 134 | 7 | int:SAAL1 | |
| Interaction | EI24 interactions | 2.73e-04 | 86 | 134 | 5 | int:EI24 | |
| Interaction | DHRS7 interactions | 3.37e-04 | 139 | 134 | 6 | int:DHRS7 | |
| Interaction | FAM241B interactions | 3.37e-04 | 90 | 134 | 5 | int:FAM241B | |
| Interaction | FDFT1 interactions | 3.50e-04 | 140 | 134 | 6 | int:FDFT1 | |
| Interaction | MIGA2 interactions | 3.50e-04 | 21 | 134 | 3 | int:MIGA2 | |
| Interaction | STX18 interactions | 3.63e-04 | 141 | 134 | 6 | int:STX18 | |
| Interaction | ATP2B2 interactions | 3.64e-04 | 198 | 134 | 7 | int:ATP2B2 | |
| Interaction | TM9SF1 interactions | 3.67e-04 | 51 | 134 | 4 | int:TM9SF1 | |
| Interaction | KDELR3 interactions | 3.67e-04 | 51 | 134 | 4 | int:KDELR3 | |
| Interaction | LAMP1 interactions | TMPRSS4 HUWE1 SPPL2B SLC7A11 SLC18B1 SLC38A1 PROM1 SLC7A2 BCAP31 SLC30A5 SLC22A5 SLC38A7 STEAP3 | 3.68e-04 | 644 | 134 | 13 | int:LAMP1 |
| Interaction | UBE2J1 interactions | 3.76e-04 | 199 | 134 | 7 | int:UBE2J1 | |
| Interaction | FUT8 interactions | 3.77e-04 | 142 | 134 | 6 | int:FUT8 | |
| Interaction | TMEM131L interactions | 3.92e-04 | 93 | 134 | 5 | int:TMEM131L | |
| Interaction | EPCAM interactions | 4.04e-04 | 22 | 134 | 3 | int:EPCAM | |
| Interaction | TMEM214 interactions | 4.38e-04 | 146 | 134 | 6 | int:TMEM214 | |
| Interaction | SPCS2 interactions | 4.87e-04 | 149 | 134 | 6 | int:SPCS2 | |
| Interaction | DOLK interactions | 4.90e-04 | 55 | 134 | 4 | int:DOLK | |
| Interaction | OPALIN interactions | 5.04e-04 | 209 | 134 | 7 | int:OPALIN | |
| Interaction | VKORC1L1 interactions | 5.23e-04 | 99 | 134 | 5 | int:VKORC1L1 | |
| Interaction | GPR180 interactions | 5.25e-04 | 24 | 134 | 3 | int:GPR180 | |
| Interaction | VAMP2 interactions | 5.49e-04 | 212 | 134 | 7 | int:VAMP2 | |
| Interaction | NPTN interactions | 5.52e-04 | 278 | 134 | 8 | int:NPTN | |
| Interaction | ATP2C1 interactions | 5.73e-04 | 101 | 134 | 5 | int:ATP2C1 | |
| Interaction | SCN3B interactions | 5.80e-04 | 214 | 134 | 7 | int:SCN3B | |
| Interaction | GPAT3 interactions | 5.99e-04 | 102 | 134 | 5 | int:GPAT3 | |
| Interaction | XPO4 interactions | 5.99e-04 | 102 | 134 | 5 | int:XPO4 | |
| Interaction | GPR17 interactions | 6.21e-04 | 283 | 134 | 8 | int:GPR17 | |
| Interaction | EMC7 interactions | 6.21e-04 | 156 | 134 | 6 | int:EMC7 | |
| Interaction | MFSD8 interactions | 6.41e-04 | 59 | 134 | 4 | int:MFSD8 | |
| Interaction | TRPC7 interactions | 6.47e-04 | 6 | 134 | 2 | int:TRPC7 | |
| Interaction | SPTLC1 interactions | 6.86e-04 | 159 | 134 | 6 | int:SPTLC1 | |
| Interaction | ELOVL2 interactions | 7.27e-04 | 61 | 134 | 4 | int:ELOVL2 | |
| Interaction | SUN1 interactions | 7.33e-04 | 161 | 134 | 6 | int:SUN1 | |
| Interaction | MBOAT2 interactions | 7.48e-04 | 27 | 134 | 3 | int:MBOAT2 | |
| Interaction | VEZT interactions | 7.57e-04 | 162 | 134 | 6 | int:VEZT | |
| Interaction | EXTL3 interactions | 7.77e-04 | 108 | 134 | 5 | int:EXTL3 | |
| Interaction | HTR3A interactions | 7.77e-04 | 108 | 134 | 5 | int:HTR3A | |
| Interaction | TMEM9 interactions | 8.00e-04 | 226 | 134 | 7 | int:TMEM9 | |
| Interaction | SLC30A6 interactions | 8.10e-04 | 109 | 134 | 5 | int:SLC30A6 | |
| Interaction | TYW1 interactions | 8.10e-04 | 109 | 134 | 5 | int:TYW1 | |
| Interaction | NTSR1 interactions | 8.22e-04 | 63 | 134 | 4 | int:NTSR1 | |
| Interaction | SMPD4 interactions | 8.33e-04 | 165 | 134 | 6 | int:SMPD4 | |
| Interaction | CCDC47 interactions | NAT14 TRPC6 HUWE1 DRG1 BCAP31 LMBR1L SEC62 ALG8 HSD17B11 ALG6 | 8.37e-04 | 448 | 134 | 10 | int:CCDC47 |
| Interaction | JPH1 interactions | 8.42e-04 | 228 | 134 | 7 | int:JPH1 | |
| Interaction | GPR42 interactions | 8.80e-04 | 111 | 134 | 5 | int:GPR42 | |
| Interaction | TRARG1 interactions | 8.80e-04 | 111 | 134 | 5 | int:TRARG1 | |
| Interaction | TTYH1 interactions | 9.06e-04 | 300 | 134 | 8 | int:TTYH1 | |
| Interaction | CDK5RAP3 interactions | 9.15e-04 | 168 | 134 | 6 | int:CDK5RAP3 | |
| Interaction | NEU1 interactions | 9.24e-04 | 65 | 134 | 4 | int:NEU1 | |
| Interaction | SLC39A14 interactions | 9.53e-04 | 113 | 134 | 5 | int:SLC39A14 | |
| Interaction | B3GAT1 interactions | ABCA3 ZMPSTE24 SLC38A1 SLC7A2 BCAP31 SLC30A5 SEC62 STEAP3 SMCR8 | 9.55e-04 | 377 | 134 | 9 | int:B3GAT1 |
| Interaction | CISD2 interactions | 9.56e-04 | 233 | 134 | 7 | int:CISD2 | |
| Cytoband | 17p13 | 1.68e-04 | 34 | 144 | 3 | 17p13 | |
| Cytoband | 12p13.2 | 3.89e-04 | 45 | 144 | 3 | 12p13.2 | |
| GeneFamily | Solute carriers | SLC10A3 SLC7A11 SLC18B1 SLCO1B7 SLC38A1 SLC7A2 SLC10A1 SLC30A5 SLC18A2 SLC22A3 SLC22A5 SLC38A7 SLC41A1 SLC4A5 SLC38A6 | 5.86e-09 | 395 | 102 | 15 | 752 |
| GeneFamily | Proteases, serine|STEAP family | 1.73e-06 | 5 | 102 | 3 | 1324 | |
| GeneFamily | Taste 2 receptors | 2.56e-06 | 39 | 102 | 5 | 1162 | |
| GeneFamily | Alpha-1,3-glucosyltransferases | 3.15e-05 | 2 | 102 | 2 | 447 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.83e-05 | 163 | 102 | 7 | 590 | |
| GeneFamily | ATP binding cassette subfamily A | 6.07e-05 | 14 | 102 | 3 | 805 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 3.12e-04 | 5 | 102 | 2 | 747 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily F | 3.12e-04 | 5 | 102 | 2 | 916 | |
| GeneFamily | Transmembrane channel likes | 8.63e-04 | 8 | 102 | 2 | 1135 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.15e-03 | 15 | 102 | 2 | 458 | |
| GeneFamily | Proteases, serine | 5.42e-03 | 63 | 102 | 3 | 738 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.77e-03 | 78 | 102 | 3 | 262 | |
| GeneFamily | Transient receptor potential cation channels | 1.08e-02 | 28 | 102 | 2 | 249 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-07 | 192 | 141 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-06 | 169 | 141 | 7 | f2f2ac2c9991c7cbc62e24a633e58f98b6274e6b | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-06 | 184 | 141 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-06 | 185 | 141 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.09e-05 | 157 | 141 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 161 | 141 | 6 | 16f77e7a5444d2f2b210362816cd7a07b9b42af6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 161 | 141 | 6 | f5821f551cf5c64c9f75cdb723492c87aac1ece0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 161 | 141 | 6 | 58a32a1033f379579697bda1bbf047a088e4a34f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.35e-05 | 163 | 141 | 6 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 166 | 141 | 6 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 172 | 141 | 6 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.83e-05 | 172 | 141 | 6 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 172 | 141 | 6 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | facs-Aorta-Heart-24m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 86aa15cf5c450465290de1c3dd9ff9d355d9cbee | |
| ToppCell | facs-Aorta-Heart-24m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 2216e36c77cb3b531508f897c1e7e01b94037d5e | |
| ToppCell | facs-Aorta-Heart-24m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | a3a09fe5cdb9e91e0880e247bf8d974fe29c6fa8 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-05 | 174 | 141 | 6 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-05 | 174 | 141 | 6 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.02e-05 | 175 | 141 | 6 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.02e-05 | 175 | 141 | 6 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-05 | 177 | 141 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-05 | 177 | 141 | 6 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 178 | 141 | 6 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 2.22e-05 | 178 | 141 | 6 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 2.22e-05 | 178 | 141 | 6 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 178 | 141 | 6 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.36e-05 | 180 | 141 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 182 | 141 | 6 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 182 | 141 | 6 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 182 | 141 | 6 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 183 | 141 | 6 | 7eaa6ef7c6cf848fd6489f97677f4406318da22f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.67e-05 | 184 | 141 | 6 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 185 | 141 | 6 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 186 | 141 | 6 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 186 | 141 | 6 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.84e-05 | 186 | 141 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 186 | 141 | 6 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-05 | 188 | 141 | 6 | 36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 3.11e-05 | 189 | 141 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 190 | 141 | 6 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 190 | 141 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.30e-05 | 191 | 141 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 192 | 141 | 6 | 6d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 192 | 141 | 6 | 2c6406bc97c3224099b94a43f2890f057b528fa6 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.39e-05 | 192 | 141 | 6 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-05 | 192 | 141 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 192 | 141 | 6 | 47aed7c8e6f5ce1084821212a04f568319e65fd6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 193 | 141 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 193 | 141 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-05 | 193 | 141 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 193 | 141 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-05 | 194 | 141 | 6 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-05 | 194 | 141 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.60e-05 | 194 | 141 | 6 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 194 | 141 | 6 | ef0fa9daecd3bf43c6cf56345928cacdbee19779 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 195 | 141 | 6 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-05 | 197 | 141 | 6 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.92e-05 | 197 | 141 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.92e-05 | 197 | 141 | 6 | 72775eb6c24cfb956436642ac9cd6e4d5c01ea5f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.92e-05 | 197 | 141 | 6 | 075044c17f1c52008cd3c292c15cbf485b50411e | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.92e-05 | 197 | 141 | 6 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-05 | 198 | 141 | 6 | 829377071f65016d31d09175a43c28e95532b404 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-05 | 198 | 141 | 6 | 27a3c1c5ac855dff8d63f44eaa289be3f5bd621a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.03e-05 | 198 | 141 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | af682919a874d60f579e854c274dc47063015ea9 | |
| ToppCell | VE-CD8|VE / Condition, Cell_class and T cell subcluster | 4.14e-05 | 199 | 141 | 6 | 9ae4d3e93b6e0861258e567c901ec34f04ded547 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 199 | 141 | 6 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 4.14e-05 | 199 | 141 | 6 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | LPS_only-Hematopoietic_Myeloid|LPS_only / Treatment groups by lineage, cell group, cell type | 4.14e-05 | 199 | 141 | 6 | 20523dee39a4c5f6423259920f108127b47525c4 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 199 | 141 | 6 | a4785c1921a3de18a9190e4d674ede6a90f80004 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | 3504aeba7b30cac9c428ba3871c072e2202752b4 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.26e-05 | 200 | 141 | 6 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | c5afebbc16024c60e84a67be81c78b0bfb73ec68 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 5.02e-05 | 206 | 141 | 6 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.86e-05 | 145 | 141 | 5 | e381fd90fdaf2ff8c0d2584b6e0a4506418c9593 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 149 | 141 | 5 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 151 | 141 | 5 | 9702575e47ececcf0a9f0f20a4a920dbb1ba5657 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 151 | 141 | 5 | 673e4ab117b723c14d1df3804bbedc9e48284a9d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 152 | 141 | 5 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 152 | 141 | 5 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 152 | 141 | 5 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.27e-04 | 153 | 141 | 5 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 1.35e-04 | 155 | 141 | 5 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-04 | 156 | 141 | 5 | 96747447ba7dc2c10079cee44394b19ce60b2f41 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 158 | 141 | 5 | bdfa3aa1ffc025d846f14ccb3ca84d889916021f | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.57e-07 | 197 | 131 | 9 | EFO_0005680 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.88e-06 | 50 | 131 | 5 | EFO_0022303 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.95e-06 | 7 | 131 | 3 | EFO_0004614, EFO_0006925 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.19e-06 | 51 | 131 | 5 | EFO_0022302 | |
| Disease | triglycerides in HDL measurement | 3.86e-06 | 53 | 131 | 5 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 3.86e-06 | 53 | 131 | 5 | EFO_0022286 | |
| Disease | triglycerides in very large HDL measurement | 4.65e-06 | 55 | 131 | 5 | EFO_0022324 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 6.60e-06 | 59 | 131 | 5 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 7.17e-06 | 60 | 131 | 5 | EFO_0021898 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.81e-06 | 225 | 131 | 8 | EFO_0008317, EFO_0020947 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 8.44e-06 | 62 | 131 | 5 | EFO_0022306 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 8.44e-06 | 62 | 131 | 5 | EFO_0022263 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 9.13e-06 | 63 | 131 | 5 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 9.13e-06 | 63 | 131 | 5 | EFO_0022292 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.06e-05 | 31 | 131 | 4 | EFO_0022249 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.55e-05 | 34 | 131 | 4 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.60e-05 | 78 | 131 | 5 | EFO_0022187 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 3.74e-05 | 15 | 131 | 3 | EFO_0022328 | |
| Disease | saturated fatty acids measurement | 4.80e-05 | 45 | 131 | 4 | EFO_0022304 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 5.56e-05 | 17 | 131 | 3 | EFO_0022232 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.79e-05 | 150 | 131 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | total lipids in lipoprotein particles measurement | 6.21e-05 | 48 | 131 | 4 | EFO_0022309 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.46e-05 | 153 | 131 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 6.65e-05 | 224 | 131 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 6.72e-05 | 95 | 131 | 5 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | phospholipids:total lipids ratio | 7.23e-05 | 227 | 131 | 7 | EFO_0020946 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 7.29e-05 | 50 | 131 | 4 | EFO_0022334 | |
| Disease | cholesterol to total lipids in small HDL percentage | 7.89e-05 | 51 | 131 | 4 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 7.89e-05 | 51 | 131 | 4 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 7.89e-05 | 51 | 131 | 4 | EFO_0022285 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 9.18e-05 | 53 | 131 | 4 | EFO_0022340 | |
| Disease | triglycerides in medium HDL measurement | 9.88e-05 | 54 | 131 | 4 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 9.88e-05 | 54 | 131 | 4 | EFO_0022244 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.97e-05 | 239 | 131 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.07e-04 | 21 | 131 | 3 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 1.07e-04 | 21 | 131 | 3 | EFO_0022246 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.13e-04 | 106 | 131 | 5 | EFO_0008317, EFO_0008596 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.14e-04 | 56 | 131 | 4 | EFO_0022316 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.14e-04 | 56 | 131 | 4 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.14e-04 | 56 | 131 | 4 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.14e-04 | 56 | 131 | 4 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.22e-04 | 57 | 131 | 4 | EFO_0022284 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.29e-04 | 109 | 131 | 5 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | low density lipoprotein particle size measurement | 1.31e-04 | 58 | 131 | 4 | EFO_0008593 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.35e-04 | 110 | 131 | 5 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.35e-04 | 110 | 131 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.35e-04 | 110 | 131 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.40e-04 | 59 | 131 | 4 | EFO_0022337 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.40e-04 | 59 | 131 | 4 | EFO_0022289 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.49e-04 | 60 | 131 | 4 | EFO_0022282 | |
| Disease | fatty acid measurement | 1.49e-04 | 436 | 131 | 9 | EFO_0005110 | |
| Disease | cholesteryl ester measurement | 1.56e-04 | 257 | 131 | 7 | EFO_0010351 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.70e-04 | 62 | 131 | 4 | EFO_0022339 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.80e-04 | 63 | 131 | 4 | EFO_0022335 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.87e-04 | 118 | 131 | 5 | EFO_0010119 | |
| Disease | triglycerides in small LDL measurement | 2.04e-04 | 65 | 131 | 4 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 2.16e-04 | 66 | 131 | 4 | EFO_0022312 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.42e-04 | 68 | 131 | 4 | EFO_0022327 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.57e-04 | 69 | 131 | 4 | EFO_0022341 | |
| Disease | cholesterol in very large HDL measurement | 2.57e-04 | 69 | 131 | 4 | EFO_0022229 | |
| Disease | Coxsackievirus Infections | 2.90e-04 | 6 | 131 | 2 | C0010246 | |
| Disease | trefoil factor 1 measurement | 2.90e-04 | 6 | 131 | 2 | EFO_0021865 | |
| Disease | angiostatin measurement | 2.90e-04 | 6 | 131 | 2 | EFO_0008024 | |
| Disease | Myocarditis | 2.90e-04 | 6 | 131 | 2 | C0027059 | |
| Disease | Carditis | 2.90e-04 | 6 | 131 | 2 | C0869523 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.02e-04 | 72 | 131 | 4 | EFO_0022336 | |
| Disease | polyunsaturated fatty acid measurement | 3.04e-04 | 131 | 131 | 5 | EFO_0010733 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 3.36e-04 | 74 | 131 | 4 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 3.53e-04 | 75 | 131 | 4 | EFO_0022287 | |
| Disease | free cholesterol in large HDL measurement | 4.31e-04 | 79 | 131 | 4 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 4.52e-04 | 80 | 131 | 4 | EFO_0021900 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.63e-04 | 34 | 131 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.85e-04 | 222 | 131 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, phospholipid measurement | 5.00e-04 | 146 | 131 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.18e-04 | 153 | 131 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 6.90e-04 | 9 | 131 | 2 | EFO_0800517 | |
| Disease | signal-regulatory protein beta-1 measurement | 6.90e-04 | 9 | 131 | 2 | EFO_0802069 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 6.95e-04 | 39 | 131 | 3 | EFO_0022332 | |
| Disease | degree of unsaturation measurement | 6.95e-04 | 39 | 131 | 3 | EFO_0022261 | |
| Disease | Hypercholesterolemia | 6.95e-04 | 39 | 131 | 3 | C0020443 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 7.49e-04 | 40 | 131 | 3 | EFO_0004746 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 7.78e-04 | 243 | 131 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.60e-04 | 10 | 131 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 8.65e-04 | 42 | 131 | 3 | EFO_0022255 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 8.65e-04 | 42 | 131 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.99e-04 | 96 | 131 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 9.27e-04 | 43 | 131 | 3 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 9.27e-04 | 43 | 131 | 3 | EFO_0022290 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.01e-03 | 99 | 131 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 1.01e-03 | 99 | 131 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.06e-03 | 45 | 131 | 3 | EFO_0022236 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.09e-03 | 101 | 131 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.10e-03 | 260 | 131 | 6 | EFO_0008317 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.13e-03 | 102 | 131 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.13e-03 | 46 | 131 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.19e-03 | 264 | 131 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.25e-03 | 12 | 131 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 1.25e-03 | 12 | 131 | 2 | OBA_2045152 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSGEILPILQKACVI | 301 | Q99424 | |
| KSAFVATLPLLLVLA | 256 | Q6UXG8 | |
| VIKALLILTPIFGLT | 971 | Q8IZF5 | |
| TVALALVPFLLLIPK | 171 | Q5FYA8 | |
| AGIVCRITKPALLVL | 26 | P11597 | |
| SKPLLAFVVPALAIV | 741 | Q5T601 | |
| KSILLVSLPVCLVLS | 346 | Q9Y672 | |
| LLVPTCVFLVVLLAL | 691 | Q9HCU0 | |
| LGLALALKVPFFIVV | 301 | Q9BX10 | |
| IPLLVSAGLLVVILK | 691 | O95477 | |
| PAFVVILLIVILKGI | 6021 | Q8WXG9 | |
| KVLVTVLELFLPLLF | 21 | Q99758 | |
| VPVLCLLAIIFILTA | 206 | Q9H2A7 | |
| ICLFIVIVPQKLLEF | 401 | Q5I7T1 | |
| AAAVLLALLVLLVAP | 366 | Q9BXJ7 | |
| LALKILIPVTDLAAI | 296 | A6NK59 | |
| LFLCSLGLKVLPVIK | 1581 | Q9UPY3 | |
| LPLLIVCSLESFVKL | 11 | Q8NBQ5 | |
| KAIPIGIVTSLLVCF | 286 | P52569 | |
| GRFLCKLIPSIIVLN | 91 | Q16581 | |
| TLVPLLFILAVAAIK | 101 | Q9Y2Q0 | |
| FISKLETALLPTVLI | 1136 | P59510 | |
| GPFLLSAALLVLVLK | 601 | Q8IZY2 | |
| HFVLLVICKLTPGLL | 326 | A8MX76 | |
| IPLLVATALLVALLF | 36 | Q96PE5 | |
| TDLLGKCLLSPVVLA | 71 | Q13258 | |
| EPLVLTIILSLFVKL | 766 | Q75QN2 | |
| KILTVAPLFLLLSLQ | 6 | P28039 | |
| VAAVKRALLLLVPAF | 336 | Q14728 | |
| KLLILCVGAFNILVP | 196 | Q15617 | |
| LALALKAVAIVVPFP | 151 | Q6IF63 | |
| KLFAIPILLIAVFLV | 516 | P31513 | |
| PKAALLIIVLGVILT | 196 | P43362 | |
| TCNLILIVLDVLKPL | 141 | Q9Y295 | |
| IALVPVFCGLLVAKS | 191 | O95944 | |
| LFLLLPILSSAKAQV | 11 | Q16832 | |
| LLVASSFVLLPALVL | 176 | Q9Y2U2 | |
| VFVVLLLCIPFISPK | 16 | P51572 | |
| VLALFLAKLIRLPSS | 6351 | Q5CZC0 | |
| LIGVVAILVFLTKCL | 191 | Q9HA72 | |
| LLVLIVILVILFKCG | 1136 | P38570 | |
| SLLLKLIAVVFAVLL | 21 | Q53F39 | |
| LLLPVFLAVAAVKLG | 66 | Q8WUY8 | |
| PGLEKILFAVILIFC | 21 | A6NFC9 | |
| LIILPGNFLIIFTIK | 36 | Q8IXE1 | |
| SKILGTLLFIAIPIA | 321 | P09131 | |
| FLLTLALPVKIVVDL | 61 | O14626 | |
| LLRLSVFFVPIAVKG | 426 | Q96J66 | |
| LAFLIPAVELIVKLR | 231 | Q9NVP1 | |
| LSCLLVLLFVDEPKL | 3186 | Q7Z6Z7 | |
| IIILIFVLSAIVPDK | 256 | Q96IZ6 | |
| YKGIVISLVLVLIPC | 156 | Q14973 | |
| LISVLLLFVTLIPKG | 6 | P0DP73 | |
| SVPLLIVILVFLALA | 21 | Q1HG44 | |
| SLLTDCFPKILVNIL | 1281 | Q13315 | |
| QLVACLLPILISFLL | 1941 | Q86XA9 | |
| ILPVLDFCKVFLISG | 176 | Q9P2N7 | |
| LLDLFISSACLIPVK | 1171 | Q8WZ74 | |
| TCGTTLLLKALVPLL | 81 | P17707 | |
| TKALLAFVIPALAIV | 601 | Q8IZF7 | |
| IVPLIVCAIFIFIKR | 706 | Q13443 | |
| VVLLLLLFLKSAAPE | 6 | P08519 | |
| AVKATLVLLPLLGIT | 341 | P34998 | |
| IVKLLGLDVPSLCLA | 156 | Q9HAW0 | |
| LIKLPNSLIVLTCFG | 1191 | Q0VDD8 | |
| LCLVFVPKLITLRTN | 736 | O75899 | |
| LTIFILFPLKLVEKC | 6 | O60931 | |
| LISVLLLFVTLIPKG | 6 | P0DP74 | |
| PLLIVVYKVLATLGL | 56 | Q6UWU4 | |
| CILLPVSSLLLYIIK | 176 | O75844 | |
| ILPLKESLCRVGVFL | 436 | Q8WVV5 | |
| ILVLLVSFCLLLVPA | 231 | O43889 | |
| LLLLIAPCVLKFIKN | 531 | P60507 | |
| PLFILLLLDVGCKVK | 271 | P21453 | |
| LELPLIIFGILASIC | 496 | O75751 | |
| KAPLTISLFFVGVLL | 141 | O76082 | |
| LAVLPLITKCAPLFA | 2556 | P21817 | |
| CAALLAKSGIIPALI | 581 | Q92845 | |
| LTTSLLIFIAIKCPI | 281 | Q9H756 | |
| APFSSLKVIILLCAL | 676 | O75473 | |
| IKFILLVVVPLPACL | 801 | O75473 | |
| LDIVLCLTVIPKVLA | 76 | Q8NGH5 | |
| IVPSILFLFLGLKQV | 861 | O15397 | |
| VVSILVLTIPFLLIC | 206 | Q8NGQ4 | |
| ITGFILPEKICLLLE | 281 | O75818 | |
| GLPFILILLAKLCFQ | 166 | Q96EX2 | |
| ALKCLIVALPKIILA | 276 | Q96EX2 | |
| FIPLITVKSCLDLLV | 416 | Q9NYV6 | |
| KSVVLVILLGPLVFL | 126 | P59542 | |
| KSVVLVILLGPLLFL | 126 | P59541 | |
| VPLTLTLISFLLLIC | 186 | P59541 | |
| KSVVLVILLGPLVFL | 126 | P0DSN6 | |
| KSVILVVLLGPLLFL | 126 | P59539 | |
| KSVVLVILLGPLLFL | 126 | P59540 | |
| PGLFLLLVSCVLLAK | 291 | Q9NRR2 | |
| LIALPKVGLIAFVIN | 231 | Q6NT16 | |
| ISFLGVLLLLVCTPL | 201 | Q6UX01 | |
| VVLLLLLFLKSAPTE | 6 | Q16609 | |
| ATVFLLPALIFAVKL | 801 | O43490 | |
| TVKLCILFAVLLTVP | 331 | Q8IZM9 | |
| VILALTPLFLASAVL | 26 | Q7Z3B0 | |
| IALLFLCLLPLIVKH | 126 | Q8N7X8 | |
| TLLLALFIPDIGKVI | 381 | Q9NVC3 | |
| KVTEVFILVPALLGL | 131 | Q8IVJ1 | |
| LVLPSIVILGKIILF | 436 | Q8NFT2 | |
| IVILGKIILFLPCIS | 441 | Q8NFT2 | |
| LKVALIFPVLVLLTV | 581 | G3V0H7 | |
| LFGKISLGILIFVLI | 6 | Q9BZV3 | |
| ALLLLCGKETLIPVF | 21 | Q96LB1 | |
| CGKETLIPVFLILFI | 26 | Q96LB1 | |
| LAVPSAVALVLFLIL | 321 | O43556 | |
| LIIIDLKDCFFTIPL | 1041 | P63128 | |
| AIVRKLVTALAIFVP | 741 | Q8TEV9 | |
| LLIAFLLGPKVLLVV | 371 | Q5TFQ8 | |
| ALALGVTLLKCLLIP | 16 | Q9BVK2 | |
| FVKVPILLILVTAIL | 156 | A8K4G0 | |
| IAGPICNLKFVTLLV | 6 | Q9UQC9 | |
| LKFFPIIVIGIIALI | 46 | P57727 | |
| KLLKPLLVFTFIICG | 276 | Q7Z2D5 | |
| FCKLTAILIIIVPGV | 196 | Q9UPY5 | |
| VFAPVVLGLKAITLA | 291 | Q5JXA9 | |
| LVFLAGIALTKPDLI | 71 | Q8IYN0 | |
| PTTVILLILLCFEGL | 211 | Q9NYG2 | |
| TVKAIAIVIPCILAL | 561 | P51512 | |
| LILVIAVIAATLFPL | 201 | Q99442 | |
| LLVPCVVILAKALFL | 436 | Q658P3 | |
| VVILAKALFLLPCIS | 441 | Q658P3 | |
| VLLCLLDLFPILEKT | 311 | Q6NXR4 | |
| LAVALLIQFPRKLLC | 496 | Q7Z404 | |
| KALTLLLSVCVPGLF | 111 | Q9BTD3 | |
| LLSVCVPGLFLLLVA | 116 | Q9BTD3 | |
| NLAILGLLVSKPYVI | 36 | Q96K75 | |
| RLPTFKACTLLLLVL | 341 | Q8TCT7 | |
| KVGIPIIIALLSLAS | 31 | Q9NRS4 | |
| VFIASISLKPCILVL | 421 | Q6P2S7 | |
| FISLITVKPCLDLLV | 41 | Q2M238 | |
| ILTGISVFLAPILKC | 936 | Q9BY07 | |
| VLGLIIPCTVLVIKF | 421 | Q687X5 | |
| LTPLKLVGLVCIFLA | 16 | Q9BQJ4 | |
| GILVVFSFIKEAILP | 176 | Q6UWH6 | |
| VAVLKTVILGLLCLL | 196 | Q9UKJ0 | |
| LKSIIALLVPAEALL | 231 | Q401N2 | |
| LVFLAGIAVSKPDLI | 71 | Q9H8G1 | |
| ILIFLSVVPLIKDAC | 631 | Q8TAD4 | |
| SVVPLIKDACQVLLL | 636 | Q8TAD4 | |
| LIKTTLPTLNVFLVC | 1051 | Q01118 | |
| VIGKLVVLNLFIALL | 796 | Q9UI33 | |
| LIIIDLKDCFFTIPL | 121 | Q9WJR5 | |
| KFLVVLAVAIGLPFL | 406 | Q9Y210 | |
| VGKTAPFLVLAALVL | 246 | Q05940 | |
| FLGIIVSKPDLITCL | 51 | Q96H40 | |
| VTFGIILPLCLLKNL | 201 | Q9H2H9 | |
| IAVGFCLPLLRKILL | 786 | Q6PFW1 | |
| IKCLVVLVVALGLPF | 336 | Q13507 | |
| LPLFIVTLCRTINVK | 236 | P49815 | |
| SPLLPAIATLKFIII | 561 | Q7Z402 |